| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e658d711b9cd91279d8631b9786919da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e1bf06f55de84b78abc9a057807f7eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b0bc0e7154bc580c4d07e4fb3484014 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-179
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-752
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 |
| filingDate |
2008-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5c40b97be4b30928e9d7b94aa5be835
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91ab486dc5ea011d5a4ccb99e0e26f1d |
| publicationDate |
2009-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009084275-A1 |
| titleOfInvention |
Composition for oral administration |
| abstract |
Disclosed are: a composition which is highly safe and has an excellent effect of reducing a body fat and a neutral fat such as a visceral fat and a subcutaneous fat; and a food, a pharmaceutical preparation and a feed each comprising the composition. Specifically disclosed is a composition for oral administration, which comprises a carotenoid and a sphingolipid or a carotenoid and a flavonoid and/or a derivative thereof, preferably cryptoxanthin and a sphingolipid or cryptoxanthin and a flavonoid and/or a derivative thereof. Cryptoxanthin and/or the sphingolipid and/or the flavonoid may be derived from a citrus fruit. Preferably the citrus fruit is Unshu mandarin orange. The composition has an effect of reducing a body fat and/or an effect of reducing a neutral fat. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10849336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017212999-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015027277-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015016234-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10006068-B2 |
| priorityDate |
2007-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |